ZLB BIOPLASMA AG has a total of 40 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), Hungary and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and chemical engineering are ALTAREX MEDICAL CORP, IMMUNOMEDICS INC and THERAPURE BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 11 | |
#2 | Hungary | 5 | |
#3 | Australia | 4 | |
#4 | Poland | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Canada | 2 | |
#7 | Finland | 2 | |
#8 | New Zealand | 2 | |
#9 | Slovakia | 2 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Norway | 1 | |
#13 | Taiwan | 1 | |
#14 | United States | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Chemical engineering | |
#4 | Measurement | |
#5 | Machines | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Separation | |
#5 | Analysing materials | |
#6 | Unspecified technologies | |
#7 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Lerch Peter | 12 |
#2 | Hodler Gerhard | 9 |
#3 | Morgenthaler Jean-Jacques | 8 |
#4 | Rentsch Markus | 7 |
#5 | Maring Jacques-Andre | 7 |
#6 | Noll Georg | 6 |
#7 | Luscher Thomas F | 5 |
#8 | Foertsch Vreni | 3 |
#9 | Gennari Katharina | 3 |
#10 | Miescher Sylvia | 3 |
Publication | Filing date | Title |
---|---|---|
EP1532983A1 | Immunoglobulin preparations having increased stability | |
CA2457840A1 | Hdl for the treatment of stroke and other ischemic conditions | |
AU2002249285A1 | Conditional autoimmune reaction by natural autoantibodies | |
EP1285662A1 | Reconstituted HDL for the treatment of stroke and ischemic conditions | |
AU8200401A | Method for treating unstable angina pectoris | |
AU3010801A | Improvement of therapeutic potential of immunoglobulin preparations | |
EP1106625A1 | Rhesus D specific peptide sequences | |
EP0937735A1 | A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions | |
EP0920509A1 | Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use | |
EP0764658A1 | Process for obtaining immunoglobulins from fractions originating from the fractionation of human blood plasma | |
EP0659767A1 | Process to prepare an anti-D immunoglobulin G concentrate and pharmaceutical compositions comprising it |